La Rosa M - Search Results

1

Role of forced expiratory flow at 25-75% as an early marker of small airways impairment in subjects with allergic rhinitis.

Marseglia GL, Cirillo I, Vizzaccaro A, Klersy C, Tosca MA, La Rosa M, Marseglia A, Licari A, Leone M, Ciprandi G. Marseglia GL, et al. Among authors: la rosa m. Allergy Asthma Proc. 2007 Jan-Feb;28(1):74-8. doi: 10.2500/aap.2007.28.2920. Allergy Asthma Proc. 2007. PMID: 17390762

2

Recent developments in United airways disease.

Ciprandi G, Caimmi D, Miraglia Del Giudice M, La Rosa M, Salpietro C, Marseglia GL. Ciprandi G, et al. Among authors: la rosa m. Allergy Asthma Immunol Res. 2012 Jul;4(4):171-7. doi: 10.4168/aair.2012.4.4.171. Epub 2012 Feb 8. Allergy Asthma Immunol Res. 2012. PMID: 22754709 Free PMC article.

3

Sublingual immunotherapy: an update on immunologic and functional effects.

Ciprandi G, Fenoglio D, Cirillo I, Tosca MA, La Rosa M, Licari A, Marseglia A, Barberi S, Marseglia GL. Ciprandi G, et al. Among authors: la rosa m. Allergy Asthma Proc. 2007 Jan-Feb;28(1):40-3. doi: 10.2500/aap.2007.28.2974. Allergy Asthma Proc. 2007. PMID: 17390756 Review.

4

Ebastine improves nasal symptoms and airflow and affects response to decongestion test in patients with persistent allergic rhinitis: a pilot study.

Ciprandi G, Cirillo I, Mora F, La Rosa M. Ciprandi G, et al. Among authors: la rosa m. Allergy Asthma Proc. 2007 Sep-Oct;28(5):578-81. doi: 10.2500/aap.2007.28.3029. Allergy Asthma Proc. 2007. PMID: 17883885

5

A forced expiratory flow at 25-75% value <65% of predicted should be considered abnormal: a real-world, cross-sectional study.

Ciprandi G, Capasso M, Tosca M, Salpietro C, Salpietro A, Marseglia G, La Rosa M. Ciprandi G, et al. Among authors: la rosa m. Allergy Asthma Proc. 2012 Jan-Feb;33(1):e5-8. doi: 10.2500/aap.2012.33.3524. Allergy Asthma Proc. 2012. PMID: 22370528

6

Montelukast in allergic diseases beyond asthma.

Leonardi S, Marchese G, Marseglia GL, La Rosa M. Leonardi S, et al. Among authors: la rosa m. Allergy Asthma Proc. 2007 May-Jun;28(3):287-91. doi: 10.2500/aap.2007.28.2955. Allergy Asthma Proc. 2007. PMID: 17619556 Review.

7

Serum IL-23 strongly and inversely correlates with FEV1 in asthmatic children.

Ciprandi G, Cuppari C, Salpietro AM, Tosca MA, Rigoli L, Grasso L, La Rosa M, Marseglia GL, Del Giudice MM, Salpietro C. Ciprandi G, et al. Among authors: la rosa m. Int Arch Allergy Immunol. 2012;159(2):183-6. doi: 10.1159/000336418. Epub 2012 Jun 1. Int Arch Allergy Immunol. 2012. PMID: 22678234

8

Body mass index is related with bronchial function and reversibility in children with allergic rhinitis and asthma.

Ciprandi G, Brambilla I, Tosca MA, Arrigo T, Salpietro A, Leonardi S, La Rosa M, Marseglia GL. Ciprandi G, et al. Among authors: la rosa m. Int J Immunopathol Pharmacol. 2011 Oct;24(4 Suppl):21-4. doi: 10.1177/03946320110240S405. Int J Immunopathol Pharmacol. 2011. PMID: 22032782 Free article.

9

Impaired spirometry may suggest sensitization.

Ciprandi G, Salpietro A, Leonardi S, Tosca MA, Miraglia Del Giudice M, Salpietro C, La Rosa M, Cirillo I, Signori A, Marseglia GL. Ciprandi G, et al. Among authors: la rosa m. J Biol Regul Homeost Agents. 2012 Jan-Mar;26(1 Suppl):S15-7. J Biol Regul Homeost Agents. 2012. PMID: 22691245

10

Impaired FEF25-75 values may predict bronchial reversibility in allergic children with rhinitis or asthma.

Ciprandi G, Capasso M, Leonardi S, Lionetti E, La Rosa M, Salpietro C, Miraglia Del Giudice M, Cirillo I, Tosca M, Marseglia GL. Ciprandi G, et al. Among authors: la rosa m. J Biol Regul Homeost Agents. 2012 Jan-Mar;26(1 Suppl):S19-25. J Biol Regul Homeost Agents. 2012. PMID: 22691246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

362 results

Search Page